Ourvita UK Limited 14228022 false 2025-01-01 2025-12-31 2025-12-31 The principal activity of the company is Management Consultancy activities other than financial management and wholesale of nutritional supplements Digita Accounts Production Advanced 6.30.9574.0 true true true 14228022 2025-01-01 2025-12-31 14228022 2025-12-31 14228022 bus:OrdinaryShareClass1 2025-12-31 14228022 core:RetainedEarningsAccumulatedLosses 2025-12-31 14228022 core:ShareCapital 2025-12-31 14228022 core:CurrentFinancialInstruments 2025-12-31 14228022 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 14228022 core:WithinOneYear 2025-12-31 14228022 core:OtherRelatedParties 2025-12-31 14228022 core:ParentEntities 2025-12-31 14228022 bus:SmallEntities 2025-01-01 2025-12-31 14228022 bus:Audited 2025-01-01 2025-12-31 14228022 bus:FilletedAccounts 2025-01-01 2025-12-31 14228022 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 14228022 bus:RegisteredOffice 2025-01-01 2025-12-31 14228022 bus:Director5 2025-01-01 2025-12-31 14228022 bus:Director6 2025-01-01 2025-12-31 14228022 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 14228022 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 14228022 core:OfficeEquipment 2025-01-01 2025-12-31 14228022 core:OtherRelatedParties 2025-01-01 2025-12-31 14228022 core:OtherRelatedParties core:RenderingOrReceivingServices 2025-01-01 2025-12-31 14228022 core:OtherRelatedParties core:SaleOrPurchaseGoods 2025-01-01 2025-12-31 14228022 core:ParentEntities 2025-01-01 2025-12-31 14228022 core:ParentEntities core:RenderingOrReceivingServices 2025-01-01 2025-12-31 14228022 core:ParentEntities core:SaleOrPurchaseGoods 2025-01-01 2025-12-31 14228022 1 2025-01-01 2025-12-31 14228022 countries:EnglandWales 2025-01-01 2025-12-31 14228022 2024-12-31 14228022 core:ParentEntities 2024-12-31 14228022 2024-01-01 2024-12-31 14228022 2024-12-31 14228022 bus:OrdinaryShareClass1 2024-12-31 14228022 core:RetainedEarningsAccumulatedLosses 2024-12-31 14228022 core:ShareCapital 2024-12-31 14228022 core:CurrentFinancialInstruments 2024-12-31 14228022 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 14228022 core:WithinOneYear 2024-12-31 14228022 core:ParentEntities 2024-12-31 14228022 core:ParentEntities 2024-01-01 2024-12-31 14228022 core:ParentEntities core:RenderingOrReceivingServices 2024-01-01 2024-12-31 14228022 2023-12-31 14228022 core:ParentEntities 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 14228022

Ourvita UK Limited

Filleted Financial Statements

for the year ended 31 December 2025
 

 

Ourvita UK Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3 to 8

 

Ourvita UK Limited

Company Information

Directors

Mrs R Holmes

Dr M A Brommer

Registered office

15 Olympic Court Boardmans Way
Whitehills Business Park
Blackpool
Lancashire
United Kingdom
FY4 5GU

 

Ourvita UK Limited

(Registration number: 14228022)
Balance Sheet as at 31 December 2025

Note

2025
£

2024
£

Current assets

 

Stocks

4

214,568

-

Debtors

5

996,293

317,583

Cash at bank and in hand

 

928,767

9,442

 

2,139,628

327,025

Creditors: Amounts falling due within one year

6

(2,406,101)

(259,951)

Net (liabilities)/assets

 

(266,473)

67,074

Capital and Reserves

 

Called up share capital

1,000

1,000

Retained Earnings

(267,473)

66,074

Shareholders' (deficit)/funds

 

(266,473)

67,074

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 18 September 2026 and signed on its behalf by:
 

.........................................
Mrs R Holmes
Director

 

Ourvita UK Limited

Notes to the Financial Statements for the year ended 31 December 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
15 Olympic Court Boardmans Way
Whitehills Business Park
Blackpool
Lancashire
FY4 5GU
United Kingdom

These financial statements were authorised for issue by the Board on 18 September 2026.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The presentation currency is £ Sterling.

Going concern

The financial statements have been prepared on a going concern basis, with management having given due consideration to the company’s ability to continue as a going concern for at least the next twelve months.

Audit report

The Independent Auditor's Report was unqualified. The name of the Senior Statutory Auditor who signed the audit report on 25 September 2026 was Deborah Walsh BA FCA, who signed for and on behalf of Horne Brooke Shenton.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

Ourvita UK Limited

Notes to the Financial Statements for the year ended 31 December 2025

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible Assets

Tangible Assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Depreciation method and rate for Tangible Assets

Asset class

Depreciation method and rate

Furniture, fittings and equipment

33.33% Straight Line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade Debtors

Trade Debtors are amounts due from customers for services performed in the ordinary course of business.

Trade Debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Ourvita UK Limited

Notes to the Financial Statements for the year ended 31 December 2025

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade Creditors

Trade Creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade Creditors are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade Creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2024 - 3).

4

Stocks

2025
£

2024
£

Other inventories

214,568

-

 

Ourvita UK Limited

Notes to the Financial Statements for the year ended 31 December 2025

5

Debtors

Current

2025
£

2024
£

Trade Debtors

825,929

-

Prepayments

29,858

3,363

Other debtors

4,665

20,775

Credit card account

3,129

-

VAT Control account

-

2,520

Accrued income

132,712

290,925

 

996,293

317,583

6

Creditors

Creditors: amounts falling due within one year

Note

2025
£

2024
£

Due within one year

 

Trade Creditors

 

1,588,380

14,399

Amounts owed to group undertakings and undertakings in which the company has a participating interest

9

700,851

226,112

Taxation and social security

 

46,084

2,066

Accruals and deferred income

 

46,277

12,550

Other creditors

 

24,509

4,824

 

2,406,101

259,951

 

Ourvita UK Limited

Notes to the Financial Statements for the year ended 31 December 2025

7

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary shares of £1 each

1,000

1,000

1,000

1,000

       

8

Obligations under leases and hire purchase contracts

Operating leases

The total of future minimum lease payments is as follows:

2025
£

2024
£

Not later than one year

-

1,020

The amount of non-cancellable operating lease payments recognised as an expense during the year was £Nil (2024 - £21,211).

9

Related party transactions

Summary of transactions with parent

Farmaceutici Procemsa Spa
Ourvita UK Limited is a wholly owned subsidiary of Farmaceutici Procemsa Spa
At 31st December 2025 funds held within the related company loan account in respect of Farmaceutici Procemsa Spa totalled £700,851 (2024 £226,112).

Summary of transactions with other related parties

Braveiy Holdings Limited Hong Kong
Company 93.10% owned by ultimate group parent company Nutrition Supplements Investments S.a.r.l.
During the year, Ourvita UK Limited purchased goods from Braveiy Holdings Limited for resale in the UK. The total amount of goods purchased totalled £1,532,385 (2024 - £nil).

At 31st December 2025 Ourvita UK Limited owed Braviey Holdings Limited £1,532,385.

Income and receivables from related parties

2025

Parent
£

Receipt of services

100,389

Amounts receivable from related party

100,389

2024

Parent
£

Receipt of services

290,925

Amounts receivable from related party

290,925

 

Ourvita UK Limited

Notes to the Financial Statements for the year ended 31 December 2025

Expenditure with and payables to related parties

2025

Parent
£

Other related parties
£

Purchase of goods

-

1,532,385

Rendering of services

31,728

-

31,728

1,532,385

Amounts payable to related party

31,728

1,532,385

2024

Loans from related parties

2025

Parent
£

Total
£

At start of period

226,112

226,112

Advanced

721,840

721,840

Repaid

(247,101)

(247,101)

At end of period

700,851

700,851

2024

Parent
£

Total
£

At start of period

1,104,543

1,104,543

Advanced

292,885

292,885

Repaid

(1,171,316)

(1,171,316)

At end of period

226,112

226,112

10

Parent undertaking

The company's immediate parent is Farmaceutici Procemsa Spa, incorporated in Italy.
  These financial statements are available upon request from Via Mentana 10, Nichelino (TO), 10042